Kohnen Thomas, Böhm Myriam, Herzog Michael, Hemkeppler Eva, Petermann Kerstin, Lwowski Christoph
From the Department of Ophthalmology, Goethe-University, Frankfurt am Main, Germany.
J Cataract Refract Surg. 2020 Jul;46(7):944-952. doi: 10.1097/j.jcrs.0000000000000198.
To determine improvement of near visual acuity by bilateral multifocal aspheric laser in situ keratomileusis (LASIK) treatments in presbyopic patients.
Goethe-University, Frankfurt, Germany.
Prospective, nonrandomized trial.
Thirty presbyopic patients underwent LASIK treatment with a multifocal aspheric ablation profile using an excimer laser (PresbyMAX). The first 15 patients received a multifocal aspheric ablation profile combined with micromonovision. For the consecutive 15 patients, less depth of focus was included on the distance eye (hybrid). Outcome parameters were uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), uncorrected and distance-corrected intermediate visual acuities, uncorrected near visual acuity (UNVA), and distance-corrected near visual acuity (DCNVA); manifest refraction spherical equivalent; subjective quality of vision; and spectacle independence.
The data of 29 patients were analyzed and showed that binocular CDVA changed from -0.16 ± 0.10 logarithm of the minimum angle of resolution (logMAR) preoperatively to 0.05 ± 0.20 logMAR UDVA and -0.06 ± 0.14 logMAR CDVA (P = .000, P = .001) 1 year postoperatively. Near visual acuity improved from 0.47 ± 0.13 logMAR (DCNVA) and 0.48 ± 0.26 logMAR (UNVA) to 0.19 ± 0.19 logMAR (DCNVA, P < .001) and 0.05 ± 0.15 logMAR (UNVA, P < .001). The hybrid and the μ-monovision group did not differ statistically except for a better DCNVA in the µ-monovision patients (0.21 ± 0.15 logMAR vs 0.34 ± 0.17 logMAR, P = .034). Of the hybrid and µ-monovision patients, 21 (72%) and 12 (41%) had a binocular CDVA and UDVA of 20/20 or better, 8 patients (28%) lost 1 line, 3 (10%) lost 2 lines, 4 (14%) lost 3 lines, and 2 (7%) lost 4 lines of CDVA.
The PresbyMAX laser seemed to satisfy most of the patients, although they experienced a loss of CDVA. The gain of near visual acuity and therefore reported less need of spectacles seemed to compensate for this loss.
确定双侧多焦点非球面准分子原位角膜磨镶术(LASIK)治疗老花眼患者后近视力的改善情况。
德国法兰克福歌德大学。
前瞻性、非随机试验。
30例老花眼患者使用准分子激光(PresbyMAX)接受多焦点非球面消融模式的LASIK治疗。前15例患者接受多焦点非球面消融模式联合微单眼视力矫正。对于接下来的15例患者,远距离眼的焦点深度较小(混合模式)。观察指标包括未矫正远视力(UDVA)、矫正远视力(CDVA)、未矫正和远距矫正的中间视力、未矫正近视力(UNVA)以及远距矫正近视力(DCNVA);明显屈光球镜当量;主观视觉质量;以及摆脱眼镜依赖的情况。
对29例患者的数据进行分析,结果显示双眼CDVA术前为-0.16±0.10最小分辨角对数(logMAR),术后1年变为0.05±0.20 logMAR UDVA和-0.06±0.14 logMAR CDVA(P = 0.000,P = 0.001)。近视力从0.47±0.13 logMAR(DCNVA)和0.48±0.26 logMAR(UNVA)提高到0.19±0.19 logMAR(DCNVA,P < 0.001)和0.05±0.15 logMAR(UNVA,P < 0.001)。混合模式组和微单眼视力矫正组除微单眼视力矫正组患者的DCNVA更好外(0.21±0.15 logMAR对0.34±0.17 logMAR,P = 0.034),在统计学上无差异。在混合模式组和微单眼视力矫正组患者中,分别有21例(72%)和12例(41%)的双眼CDVA和UDVA达到20/20或更好,8例患者(28%)视力下降1行,3例(10%)下降2行,4例(14%)下降3行,2例(7%)下降4行CDVA。
PresbyMAX激光似乎使大多数患者满意,尽管他们的CDVA有所下降。近视力的提高以及因此报告的对眼镜需求的减少似乎弥补了这一下降。